Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04551872 · ClinicalTrials.gov registry record · NA
RESILIENCE: Personalizing Cardiovascular Health
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 598
- Enrollment target
NCT04551872: Completed NA study, sponsored by Duke University.
NCT04551872 is a NA study that has completed, run by Duke University. The registered enrollment target is 598 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04551872, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 598 participants
- Enrollment target
Study Summary
Obesity is a rapidly growing epidemic that is associated with the development of cardiovascular disease (CVD). However, some individuals with obesity appear to be resistant to CVD, and other individuals demonstrate resilience to obesity and CVD risk factors. The investigator's overall objective is to understand factors contributing to the heterogeneity of CVD resistance and resilience among individuals with obesity at Duke.
Interventions
- BEHAVIORAL Digital weight loss intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 598 participants |
| Start Date | 2020-09-22 |
| Est. Completion | 2024-03-22 |
| Phase | NA |
What the finished NCT04551872 record still lists
NCT04551872 is an interventional study that assigns participants to a tested intervention. The registered 598 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 1 intervention - of which Digital weight loss intervention is the first listed.
NCT04551872 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04551872 about?
NCT04551872 is a clinical study titled "RESILIENCE: Personalizing Cardiovascular Health". Obesity is a rapidly growing epidemic that is associated with the development of cardiovascular disease (CVD). However, some individuals with obesity appear to be resistant to CVD, and other individuals demonstrate resilience to obesity and CVD risk factors. The investigator's overall objective is t...
What is the current status of trial NCT04551872?
This trial is currently completed. It is a NA study. The enrollment target is 598 participants. The study started on 2020-09-22. Estimated completion is 2024-03-22.
What interventions are being tested in trial NCT04551872?
The interventions under investigation include: Digital weight loss intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04551872?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04551872's enrollment target sits among peer trials
598 174th of 2000 higher than 1,827 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06875973 · 599 participants · Phase 3
Pelacarsen Roll-over Extension Program
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI